ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
임상시험 플랫폼 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 23억 6,000만 달러에서 2025년에는 26억 9,000만 달러에 달하고, CAGR 14.1%로 확대될 전망입니다. 실적기간 내 성장 원동력은 전자 데이터 수집 시스템의 채용 증가, 임상시험 관리의 중앙 집중화에 대한 수요 증가, 규제 준수 요건의 엄격화, 임상 연구의 아웃소싱 확대, 웨어러블 헬스 모니터링 디바이스의 조기 도입 등이었습니다.
임상시험 플랫폼 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 13.7%로 45억 달러로 성장할 전망입니다. 예측기간 내 성장은 분산 임상시험의 급속한 증가, 임상 플랫폼과 AI 및 머신러닝의 통합, 원격 환자 모니터링의 이용 확대, 환자 중심의 시험 설계에 대한 수요 증가, 클라우드 기반의 임상시험 솔루션의 확대에 의해 지원될 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 분산 임상시험과 원격 환자 모니터링의 통합, 시험 설계 및 데이터 분석에 AI 및 머신러닝 채택, 실시간 환자 데이터 수집을 위한 웨어러블 디바이스 및 바이오센서 사용, 시험에서 데이터 보안 및 투명성을 강화하기 위한 블록체인 활용 확대 등이 있습니다.
연구개발 투자 증가는 앞으로 수년간 임상시험 플랫폼 시장의 성장을 가속화할 것으로 예측됩니다. 연구개발(R&D) 투자는 신기술, 제품, 솔루션의 개발을 목적으로 한 혁신적인 활동에 조직이 소비하는 총액입니다. 연구개발 투자의 급증은 세계 경쟁의 격화와 급속한 기술 진보가 주요 요인이며, 기업은 끊임없이 진화하는 시장에서 경쟁력을 유지하기 위해서는 지속적인 혁신이 필수적임을 인식하고 있습니다. 연구개발비가 증가함에 따라 다양한 연구 및 치료 영역에서 복잡한 연구 워크플로, 데이터 수집, 규제 준수 요건을 관리할 수 있는 종합적인 임상시험 플랫폼에 대한 요구가 높아지고 있습니다. 예를 들어 유럽연합(EU) 통계국인 유로스타트는 2023년 12월, EU의 연구개발비가 2022년 3,520억 유로(3,844억 2,000만 달러)에 이르렀으며, 2021년 3,310억 유로(3,614억 8,000만 달러)에 비해 증가했다고 밝혔습니다. 이와 같이 R&D 투자의 성장은 임상시험 플랫폼 시장의 확대를 이끌고 있습니다.
임상시험 플랫폼 시장의 주요 기업은 임상시험 중 의사결정과 업무 효율성을 향상시키기 위해 머신러닝을 기반으로 하는 플랫폼과 같은 고급 솔루션의 개발에 주력하고 있습니다. 이 AI 구동 플랫폼은 인공지능을 사용하여 임상 데이터를 분석하고 환자 자격, 모집 패턴 및 시험 결과를 예측하고, 시험 설계를 최적화하며, 참가자 등록을 가속화합니다. 예를 들어, 미국을 기반으로 하는 AI/ML 구동 임상 개발 솔루션 제공업체인 PhaseV는 2025년 7월에 ClinOps AI 플랫폼을 발표했습니다. 이 차세대 툴은 정확한 임상시험 시설의 선택과 동적 실시간 성능 모니터링을 가능하게 함으로써 임상시험 운영에 혁명을 가져왔습니다. 이 플랫폼은 인과 관계가 있는 머신러닝과 실세계 환자 데이터를 활용하여 임상시험 팀이 데이터 주도로 신속한 의사결정을 실시하고, 임상시험시설의 성과, 환자의 편차, 모집에 대한 깊은 인사이트를 제공하여 궁극적으로 임상생활주기 전체의 효율성과 다양성을 높일 수 있게 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 임상시험 플랫폼 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 임상시험 플랫폼 시장 : 성장률 분석
세계의 임상시험 플랫폼 시장 실적 : 규모와 성장(2019-2024년)
세계의 임상시험 플랫폼 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 임상시험 플랫폼 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 임상시험 플랫폼 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
소프트웨어 솔루션
서비스
하드웨어
세계의 임상시험 플랫폼 시장 : 전개 모드별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
클라우드 기반
On-Premise
세계의 임상시험 플랫폼 시장 : 단계별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
1상
2상
3상
4상
세계의 임상시험 플랫폼 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
종양
심혈관질환
신경학
감염증
희귀질환
세계의 임상시험 플랫폼 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제약 및 생명공학 기업
계약 연구 기관
의료기기 기업
병원 및 클리닉
기타 최종 사용자 유형
세계의 임상시험 플랫폼 시장 세분화 : 소프트웨어 솔루션 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
전자 데이터 수집(EDC) 시스템
임상시험관리시스템(CTMS)
무작위배정 및 임상시험약 공급 관리(RTSM) 소프트웨어
동의 소프트웨어
안전성 및 약물감시 소프트웨어
데이터 분석 및 보고 도구
환자 모집 및 유지 소프트웨어
원격 모니터링 및 분산형 임상시험 소프트웨어
세계의 임상시험 플랫폼 시장 세분화 : 서비스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
임상시험 디자인 및 컨설팅 서비스
임상시험 관리기관(SMO)서비스
개발 업무 수탁기관(CRO) 서비스
환자 모집 및 유지 서비스
데이터 관리 서비스
규제 및 컴플라이언스 서비스
교육 및 지원 서비스
세계의 임상시험 플랫폼 시장 세분화 : 하드웨어 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
웨어러블 건강 모니터링 기기
주입 펌프 및 장치
바이오메트릭 센서
모바일 의료기기
영상 진단 기기
임상 검사 기기 및 기구
제7장 지역별/국가별 분석
세계의 임상시험 플랫폼 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 임상시험 플랫폼 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
임상시험 플랫폼 시장 : 경쟁 구도
임상시험 플랫폼 시장 : 기업 프로파일
Oracle Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Tata Consultancy Services Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
IQVIA Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Labcorp Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
ICON Public Limited Company : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Veeva Systems Inc.
Medpace Holdings Inc.
Clario Inc.
Medidata Solutions Inc.
Medable Inc.
South Australian Health and Medical Research Institute
Medrio Inc.
Ciwit BV
Obvio Health USA Inc.
Curebase Inc.
DATATRAK International Inc.
OpenClinica LLC
Infiuss Health Inc.
PhaseV Inc.
Everest Global Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
임상시험 플랫폼 시장(2029년) : 새로운 기회를 제공하는 국가
임상시험 플랫폼 시장(2029년) : 새로운 기회를 제공하는 부문
임상시험 플랫폼 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
A clinical trial platform is a digital solution designed to optimize the planning, management, and execution of clinical studies. It integrates data collection, monitoring, and analytics to improve operational efficiency. The platform delivers real-time insights that support faster decision-making and enhance trial accuracy. It streamlines task management and ensures smooth coordination across study processes, resulting in quicker and more reliable outcomes in clinical research.
The primary product types of clinical trial platforms are software solutions, services, and hardware. Software solutions consist of digital tools and systems that support trial design, patient recruitment, data collection, monitoring, and analysis to improve efficiency and compliance. Deployment modes include cloud-based and on-premises options, while clinical phases encompass phase I, phase II, phase III, and phase IV. Applications cover oncology, cardiovascular diseases, neurology, infectious diseases, and rare diseases. Key end-users include pharmaceutical and biotechnology companies, contract research organizations, medical device companies, hospitals, clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The clinical trial platform market research report is one of a series of new reports from The Business Research Company that provides clinical trial platform market statistics, including clinical trial platform industry global market size, regional shares, competitors with a clinical trial platform market share, detailed clinical trial platform market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial platform industry. The clinical trial platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The clinical trial platform market size has grown rapidly in recent years. It will grow from $2.36 billion in 2024 to $2.69 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. Growth in the historic period was driven by the rising adoption of electronic data capture systems, increasing demand for centralized clinical trial management, stricter regulatory compliance requirements, expansion of outsourcing in clinical research, and early adoption of wearable health monitoring devices.
The clinical trial platform market size is expected to see rapid growth in the next few years. It will grow to $4.50 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. Growth in the forecast period is expected to be supported by the rapid rise of decentralized clinical trials, integration of AI and machine learning in clinical platforms, greater use of remote patient monitoring, rising demand for patient-centric trial designs, and the expansion of cloud-based clinical trial solutions. Key trends anticipated for the forecast period include the integration of decentralized clinical trials and remote patient monitoring, adoption of AI and machine learning for trial design and data analysis, use of wearable devices and biosensors for real-time patient data collection, and greater utilization of blockchain to enhance data security and transparency in trials.
The increasing investment in research and development is expected to drive the growth of the clinical trial platform market in the coming years. Investment in research and development (R&D) refers to the total amount spent by organizations on innovative activities aimed at creating new technologies, products, and solutions. The surge in R&D investment is primarily driven by rising global competition and rapid technological progress, as companies recognize that continuous innovation is crucial for staying competitive in an ever-evolving market. As R&D spending increases, there is a greater need for comprehensive clinical trial platforms capable of managing complex research workflows, data collection, and regulatory compliance requirements across various studies and therapeutic areas. For instance, in December 2023, Eurostat, the statistical office of the European Union, reported that the EU's expenditure on research and development rose to €352 billion ($384.42 billion) in 2022, representing a 6.34% increase from €331 billion ($361.48 billion) in 2021. As such, the growth in R&D investment is driving the expansion of the clinical trial platform market.
Key companies in the clinical trial platform market are focusing on creating advanced solutions, such as machine learning-based platforms, to improve decision-making and operational efficiency during clinical trials. These AI-driven platforms use artificial intelligence to analyze clinical data and predict patient eligibility, recruitment patterns, and trial outcomes, while optimizing study designs and speeding up participant enrollment. For example, in July 2025, PhaseV, a U.S.-based provider of AI/ML-driven clinical development solutions, launched the ClinOps AI platform. This next-generation tool is designed to revolutionize clinical trial operations by enabling precise site selection and dynamic, real-time performance monitoring. By leveraging causal machine learning and real-world patient data, the platform allows trial teams to make faster, data-driven decisions, offering deeper insights into site performance, patient variability, and recruitment, which ultimately enhances efficiency and diversity across the trial lifecycle.
In December 2024, OpenClinica Inc., a U.S.-based provider of software-as-a-service solutions for clinical trials, acquired BuildClinical Inc. for an undisclosed amount. This acquisition is aimed at speeding up patient recruitment and reducing enrollment bottlenecks in clinical trials by utilizing BuildClinical's data-driven digital engagement and enrollment strategies. BuildClinical Inc. is a health technology company based in the U.S. that provides a platform to streamline patient recruitment for academic research studies.
Major players in the clinical trial platform market are Oracle Corporation, Tata Consultancy Services Limited, IQVIA Holdings Inc., Labcorp Holdings Inc., ICON Public Limited Company, Veeva Systems Inc., Medpace Holdings Inc., Clario Inc., Medidata Solutions Inc., Medable Inc., South Australian Health and Medical Research Institute, Medrio Inc., Ciwit B.V., Obvio Health USA Inc., Curebase Inc., DATATRAK International Inc., OpenClinica LLC, Infiuss Health Inc., PhaseV Inc., Everest Global Inc.
North America was the largest region in the clinical trial platform market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical trial platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the clinical trial platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clinical trial platform market consists of revenues earned by entities by providing services such as patient recruitment and retention, data management and analytics, remote monitoring and telemedicine support, regulatory compliance and trial management, and training and consulting services. The market value includes the value of related products sold by the service provider or included within the service offering. The clinical trial platform market also includes sales of electronic data capture (EDC) systems, wearable health monitoring devices, biosensors, and clinical trial software solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream service providers, distributors, and healthcare institutions) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Trial Platform Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical trial platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for clinical trial platform ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical trial platform market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Software Solutions; Services; Hardware
2) By Deployment Mode: Cloud-Based; On-Premises
3) By Phase: Phase I; Phase II; Phase III; Phase IV
5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Medical Device Companies; Hospitals And Clinics; Other End-Users
Subsegments:
1) By Software Solutions: Electronic Data Capture (EDC) Systems; Clinical Trial Management System (CTMS); Randomization And Trial Supply Management (RTSM) Software; eConsent Software; Safety And Pharmacovigilance Software; Data Analytics And Reporting Tools; Patient Recruitment And Retention Software; Remote Monitoring And Decentralized Trial Software
2) By Services: Clinical Trial Design And Consulting Services; Site Management Organization (SMO) Services; Contract Research Organization (CRO) Services; Patient Recruitment And Retention Services; Data Management Services; Regulatory And Compliance Services; Training And Support Services
3) By Hardware: Wearable Health Monitoring Devices; Infusion Pumps And Devices; Biometric Sensors; Mobile Health Devices; Imaging And Diagnostic Devices; Laboratory Equipment And Instruments
Companies Mentioned: Oracle Corporation; Tata Consultancy Services Limited; IQVIA Holdings Inc.; Labcorp Holdings Inc.; ICON Public Limited Company; Veeva Systems Inc.; Medpace Holdings Inc.; Clario Inc.; Medidata Solutions Inc.; Medable Inc.; South Australian Health and Medical Research Institute; Medrio Inc.; Ciwit B.V.; Obvio Health USA Inc.; Curebase Inc.; DATATRAK International Inc.; OpenClinica LLC; Infiuss Health Inc.; PhaseV Inc.; Everest Global Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Clinical Trial Platform Market Characteristics
3. Clinical Trial Platform Market Trends And Strategies
4. Clinical Trial Platform Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Clinical Trial Platform Growth Analysis And Strategic Analysis Framework
5.1. Global Clinical Trial Platform PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Clinical Trial Platform Market Growth Rate Analysis
5.4. Global Clinical Trial Platform Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Clinical Trial Platform Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Clinical Trial Platform Total Addressable Market (TAM)
6. Clinical Trial Platform Market Segmentation
6.1. Global Clinical Trial Platform Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software Solutions
Services
Hardware
6.2. Global Clinical Trial Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud-Based
On-Premises
6.3. Global Clinical Trial Platform Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phase I
Phase II
Phase III
Phase IV
6.4. Global Clinical Trial Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiovascular Diseases
Neurology
Infectious Diseases
Rare Diseases
6.5. Global Clinical Trial Platform Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Contract Research Organizations
Medical Device Companies
Hospitals And Clinics
Other End-User Types
6.6. Global Clinical Trial Platform Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electronic Data Capture (EDC) Systems
Clinical Trial Management System (CTMS)
Randomization And Trial Supply Management (RTSM) Software
eConsent Software
Safety And Pharmacovigilance Software
Data Analytics And Reporting Tools
Patient Recruitment And Retention Software
Remote Monitoring And Decentralized Trial Software
6.7. Global Clinical Trial Platform Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Trial Design And Consulting Services
Site Management Organization (SMO) Services
Contract Research Organization (CRO) Services
Patient Recruitment And Retention Services
Data Management Services
Regulatory And Compliance Services
Training And Support Services
6.8. Global Clinical Trial Platform Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wearable Health Monitoring Devices
Infusion Pumps And Devices
Biometric Sensors
Mobile Health Devices
Imaging And Diagnostic Devices
Laboratory Equipment And Instruments
7. Clinical Trial Platform Market Regional And Country Analysis
7.1. Global Clinical Trial Platform Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Clinical Trial Platform Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
